Sanjay Chandrasekhar
Overview
Explore the profile of Sanjay Chandrasekhar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bennett J, Chandrasekhar S, Woods E, McLean P, Newman N, Montelaro B, et al.
Future Cardiol
. 2024 Oct;
20(14):755-778.
PMID: 39445463
Functional coronary angiography (FCA) is a novel modality for assessing the physiology of coronary lesions, going beyond anatomical visualization by traditional coronary angiography. FCA incorporates indices like fractional flow reserve...
2.
Chandrasekhar S, Woods E, Bennett J, Newman N, McLean P, Alam M, et al.
Cardiol Rev
. 2024 Sep;
PMID: 39315746
Coronary artery anomalies encompass a spectrum of congenital abnormalities affecting the origin, course, or termination of the major epicardial coronary arteries. Despite their rarity, coronary artery anomalies represent a significant...
3.
Woods E, Bennett J, Chandrasekhar S, Newman N, Rizwan A, Siddiqui R, et al.
Cardiology
. 2024 Jul;
:1-22.
PMID: 39013364
Background: Coronary artery disease (CAD) is a highly prevalent condition which can lead to myocardial ischemia as well as acute coronary syndrome. Early diagnosis of CAD can improve patient outcomes...
4.
Chandrasekhar S, Agrawal A
J Am Heart Assoc
. 2024 May;
13(11):e035545.
PMID: 38780178
No abstract available.
5.
Chandrasekhar S, Perez M, Niaz Z, Ekram J, Lal N, Koly S, et al.
Cancer Control
. 2024 Apr;
31:10732748241246898.
PMID: 38605434
Background: Percutaneous Hepatic Perfusion (PHP) is a liver directed regional therapy recently FDA approved for metastatic uveal melanoma to the liver involving percutaneous isolation of liver, saturation of the entire...
6.
Lee D, Kumar A, Mohammed T, Peres L, Alsina M, Bachmeier C, et al.
Blood Adv
. 2023 Jun;
7(16):4247-4257.
PMID: 37307173
Idecabtagene vicleucel (ide-cel) is a type of B-cell maturation antigen (BCMA)-targeting chimeric antigen receptor T-cell (CAR-T) approved for the treatment of relapsed and refractory multiple myeloma (RRMM). Currently, the incidence...
7.
Chandrasekhar S, Syed M
Postgrad Med J
. 2023 Apr;
98(e1):e10.
PMID: 37066580
No abstract available.
8.
Lee D, Chandrasekhar S, Jain M, Mhaskar R, Reid K, Lee S, et al.
Cardiooncology
. 2023 Apr;
9(1):18.
PMID: 37005652
Background: Chimeric antigen receptor T- Cell (CAR-T) immunotherapy has been a breakthrough treatment for various hematological malignancies. However, cardiotoxicities such as new-onset heart failure, arrhythmia, acute coronary syndrome and cardiovascular...
9.
Henpita C, Vyas R, Healy C, Kieu T, Gurkar A, Yousefzadeh M, et al.
Aging Cell
. 2023 Feb;
22(4):e13782.
PMID: 36734200
Cardiomyopathy is a progressive disease of the myocardium leading to impaired contractility. Genotoxic cancer therapies are known to be potent drivers of cardiomyopathy, whereas causes of spontaneous disease remain unclear....
10.
Chandrasekhar S, Lee D, Patel N, Bassily E, Chen A
Cureus
. 2021 Oct;
13(8):e17494.
PMID: 34603875
A 74-year-old male with a past medical history of mechanical aortic valve replacement presented with abdominal pain and fever. Blood cultures revealed methicillin-resistant (MRSA) and the patient was started on...